|
End-of-day quote
Nasdaq
10/09/2026
|
5-day change | 1st Jan Change | ||
| 14.79 USD | -6.10% |
|
-12.49% | +13.51% |
| 08-20 | Guggenheim Initiates Freenome at Buy With $21 Price Target | MT |
| 08-18 | Freenome Registers Up To 75.2 Million Shares For Sale | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Diagnostics & Testing
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 1.59B | - | - | - | - | - |
| 3.87B | - | ||||
| 3.69B | - | ||||
| 3.38B | |||||
| 2.59B | - | - | |||
| 2.08B | - | - | - | - |
- Stock Market
- Stocks
- FRNM Stock
- Charts Freenome, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
